ArticleBMC geriatrics2025
Development and psychometric evaluation of the sarcopenia prevention behavior adherence scale for older adults - a mixed methods study.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBehavior adherence is essential to prevent the onset and development of sarcopenic disease in the older adults. However, to date there has been no appropriate scale to measure the level of sarcopenia prevention behavior adherence in older adults. This study aims to develop and psychometrically test sarcopenia prevention behavior adherence scale for older adults.
methodsThe study was conducted in two phases: scale development and psychometric evaluation. scale development was based on literature review, expert consultation, and a pre-survey. Psychometric evaluation is based on the reliability and validity of large sample survey.
resultsA 3-dimensions 18-items scale was developed, including diet behavior, exercise behavior, and resource utilization behavior.The confirmatory factor analysis supported the three-factor model, and the convergent and discriminant validity levels were satisfactory.The Cronbach's α coefficient of the scale was 0.921 and the content validity index was 0.957.
conclusionsThe scale developed in this study is a reliable and valid tool for assessing the level of behavior adherence to sarcopenia prevention for older adults.More studies are needed to examine the robustness of its structure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.